通过使用护理点的细胞悬浮自移植,减少死亡率
Muzamil Ahmad1, Soman Sen2,3, Kathleen Romanowski2,3
1Oakland University William Beaumont School of Medicine, MI, United States.
概括
细胞悬浮自体移植 (CSA) 与分厚皮肤移植 (STSG) 结合,显著降低了成年烧伤患者的死亡率. 这项研究发现,与单独使用STSG相比,CSA使用降低了78.9%的死亡几率.
科学领域:
- 再生医学是一种再生医学.
- 烧伤手术 烧伤手术
- 临床结果研究研究
背景情况:
- 细胞悬浮自移植 (CSA) 是一种非培养的,自的细胞悬浮,用于烧伤护理.
- 关于CSA对死亡率的影响的现有文献有限,特别是当与分厚皮肤移植 (STSG) 相结合时.
- 已确认CSA在烧伤护理中改善了患者的治疗结果,但其对生存率的影响需要进一步研究.
研究的目的:
- 调查CSA在成人烧伤患者的临床疗效,当与STSG一起使用时.
- 为了比较CSA治疗和非CSA治疗组之间的死亡率,停留时间 (LOS),重症监护室LOS (ICU LOS) 和手术计数.
- 评估CSA对接受STSG的烧伤患者的生存的影响.
主要方法:
- 追溯,匹配,病例控制研究设计.
- 从2015年至2023年包括成年烧伤患者.
- 126名未接受CSA治疗的患者 (单独STSG) 与63名接受CSA治疗的患者 (CSA + STSG) 的匹配,基于第三级TBSA和年龄.
主要成果:
- 接受CSA治疗的患者显示死亡率显著降低 (p=.0445),死亡几率降低78.9% (OR:0.211).
- 在CSA治疗组的LOS (p=.0670),ICU LOS (p=.0851) 和手术数量 (p=.9084) 中观察到非显著的增加.
- 潜在的偏见包括选择和时间表,而增加的生存率可能解释非显著的LOS增加.
结论:
- 细胞悬浮自移植 (CSA) 在与分厚皮肤移植 (STSG) 一起使用时,显著提高了成年烧伤患者的生存率.
- 在CSA治疗组中观察到的LOS和ICU LOS的增加可能归因于患者存活率的增加.
- 需要进一步的研究来证实这些生存益处,并优化CSA在烧伤管理中的利用.
更多相关视频
10:30Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
Published on: December 8, 2016
10.4K
09:43Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair
Published on: February 24, 2016
10.4K
相关概念视频
01:22Bone Marrow Sampling and Transplants
829
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
829
01:19Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K